Provided by Tiger Trade Technology Pte. Ltd.

bioAffinity Technologies, Inc.

5.19
-0.6300-10.82%
Post-market: 5.250.0600+1.16%17:27 EDT
Volume:87.83K
Turnover:467.71K
Market Cap:3.07M
PE:-0.05
High:5.47
Open:5.40
Low:5.08
Close:5.82
52wk High:202.50
52wk Low:4.88
Shares:592.37K
Float Shares:532.20K
Volume Ratio:0.04
T/O Rate:16.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-103.3545
EPS(LYR):-129.9452
ROE:-1860.15%
ROA:-125.11%
PB:0.82
PE(LYR):-0.04

Loading ...

Company Profile

Company Name:
bioAffinity Technologies, Inc.
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
57
Office Location:
3300 Nacogdoches Road,Suite 216,San Antonio,Texas,United States
Zip Code:
78217
Fax:
- -
Introduction:
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.

Directors

Name
Position
Maria Zannes
Chief Executive Officer and Director and President
Steven Girgenti
Director and Executive Chairman
Jamie Platt
Independent Director
John J. Oppenheimer
Independent Director
Peter Knight
Independent Director
Robert Anderson
Independent Director
Roberto Rios
Independent Director
Roby Joyce
Director

Shareholders

Name
Position
Maria Zannes
Chief Executive Officer and Director and President
Xavier Reveles
Chief Operating Officer
Michael Edwards
Chief Financial Officer
Timothy P. Zannes
Executive Vice President, Secretary, and General Counsel